Translate

Sunday, July 31, 2016

The Globalization of International Trade and Standardization of Anti-bribery and Corruption Laws Have Led to the Enactment of International Whistleblower Laws That Reward International Professionals for Anonymously Exposing Fraud

The Globalization of International Trade and Standardization of Anti-bribery and Corruption Laws Have Led to the Enactment of International Whistleblower Laws That Reward International Professionals for Anonymously Exposing Foreign Corrupt Practices Act Violations Including Illegal Bribes, Supply Chain Fraud, and Accounting Fraud

Through globalization of international trade, there has been a shift in many international manufacturing supply chains. As such, raw material supplies for pharmaceuticals, medical supplies, medical equipment, electronics, and several other regulated products that have traditionally come from the United States and Europe are now coming from China and India. This manufacturing shift has created an environment where adulterated ingredients to pharmaceuticals, medical supplies, and medical devices as well as counterfeit parts for weapons and electronics may be used in the manufacturing of products and can create dangerous and adulterated drugs, medical supplies, and medical devices as well as dangerous and defective weapons, computers, aircraft, and vehicles.

For this reason international professionals are being offered large financial rewards to properly expose supply chain fraud including bribes, accounting fraud, and dangerous regulated products.  Under SEC FCPA whistleblower reward laws, an international professional can report these Foreign Corrupt Practice Act violations anonymously through a lawyer to protect their identity and career from potential retaliation.

The Globalization of the Pharmaceutical Industry

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications.  In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to 7% to around $880 billion.  This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland and the Ukraine.  These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

For more information on Globalization in the Pharmaceutical Industry, please go to the following web pages: Globalization in the Pharmaceutical Industry, Drug Company Bribe Whistleblowers, and Doctors in China Are Needed to Expose Illegal Drug Bribes and Fraudulent Marketing Schemes.

The Globalization of Electronics, Weapons Systems, and Aircraft

Globalization of supply chains in international trade has created a shift in where many component parts are produced.  This shift includes the production of electronic components that are used in aircraft, military weapons systems, computers, medical equipment, and other products that are purchased by the United States government through procurement contracts.  These electronic components were traditionally manufactured in the United States and Europe, but are now being manufactured in China, Mexico, India, and South America.  When these electronic components are fake or substandard parts, false certifications regarding the quality of these electronic components can be the subject of a Qui Tam False Claims Act Whistleblower Reward Lawsuit. These lawsuits encourage whistleblowers including international whistleblowers along the electronic component supply chain to blow the whistle on fake military electronic components, low quality electronic components, and other counterfeit electronic parts.

For more information on Globalization in the Electronics, Weapons Systems, and Aircraft, please go to the following web page: Globalization of Electronics, Weapons Systems, and Aircraft.

Thursday, June 16, 2016

China Drug Company Bribe Scheme Whistleblowers Can Earn Large Financial Rewards By Confidentially Reporting Illegal Bribes Through a Lawyer To The SEC by China Drug Company Bribe Whistleblower Reward Lawyer

China Drug Company Bribe Scheme Whistleblowers Can Earn Large Financial Rewards By Confidentially Reporting Illegal Bribes Through a Lawyer To The SEC by China Drug Company Bribe Whistleblower Reward Lawyer Jason S. Coomer

Under the Foreign Corrupt Practices Act and the SEC Whistleblower Incentive Program, whistleblowers with original and specialized knowledge and evidence of corporate bribery and illegal kickbacks are eligible to recover large economic awards.  By gathering this evidence and going through a lawyer, these whistleblowers can protect their identity through the process and potentially collect large rewards of 10% to 30% of the monetary sanctions including disgorged funds.  In cases where systematic bribery schemes have created large drug company revenues of over $1 billion USD, these rewards can be between $100 million USD and $300 million USD.  For more information on this topic, please go to the following web pages:  Chinese Doctors Are Needed to Expose Drug Bribery Schemes and Expose Drug Company Bribes and Earn Large Rewards.

The Chinese Drug Market Is The Target of Many Multinational Drug Companies  

The Chinese pharmaceutical market is one of the fastest growing drug markets in the world.  To capitalize on this fast growing market several drug companies are offering illegal bribes and other incentives to Chinese doctors in order to increase drug sales in China.  These illegal bribery schemes include paying Chinese doctors and Chinese health officials with gift cards, illegal trips, and slush funds to prescribe specific drugs and influence treatment guidelines.

Some of these bribery schemes are extremely complicated and involve systematic gifts given to doctors through accounting fraud and marketing fraud.  Such marketing schemes are illegal under Chinese law and can be the basis for large SEC Bounty Action Rewards.

China Drug Company Bribe Whistleblower Lawyer Jason Coomer Helping Whistleblowers Report Fraud and Claim Rewards

Jason Coomer, who heads a law firm in Austin, Texas, has a Chinese language website offering assistance to whistleblowers. His office and his co-counsel have received around 50 whistleblower reports from China in the last three years and are now taking eight cases forward to the SEC.

We're talking large multinational corporations with multi-billion dollar contracts each year. The whistleblowers are insiders at the corporations as well as doctors who have witnessed elaborate bribery schemes, he told Reuters in on telephone interview from Texas. He declined to give further details about the cases.
   

Wednesday, June 15, 2016

Chinese Doctors Can Confidentially Expose Drug Company Bribes and Earn Large Financial Rewards

Chinese Doctors Can Confidentially Expose Drug Company Bribes and Earn Large Financial Rewards by China Drug Whistleblower Lawyer Jason Coomer

Doctors and other medical professionals are being offered large financial rewards and whistleblower protections to expose drug company bribes, medical device company bribes, and medical supply company bribes.  These whistleblower protections include being able to file a bounty action through an international whistleblower lawyer in order to protect the medical professional's identity.  For more information on exposing illegal bribes and collecting large rewards, please go to the following web page: Chinese Doctors Can Confidentially Expose Drug Company Bribes.

Drug Company Bribes, Medical Device Company Bribes, and Medical Supply Company Bribes in China Can
Be The Basis For Large Bounty Action Rewards

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to
7% to around $880 billion. This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland, and Ukraine. These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicine purchases, and pharmaceutical contracts are lost to corrupt and fraudulent acts. As such, there is an international movement to reward pharmaceutical professionals and health care professionals that expose fraudulent and corrupt practices that cost hundreds of billions of dollars and cost lives. This international movement includes SEC Foreign Corrupt Practices Act Whistleblower Reward Lawsuits and traditional Qui Tam False Claims Act Whistleblower Reward Lawsuits which offer whistleblowers large rewards for properly exposing bribes.  Medical providers with first hand knowledge or evidence of large bribes are encouraged to step forward to properly expose these illegal bribes.